. Hepatic resection and liver transplantation are the mainstays of surgical management for HCC, but the 5-year survival rate is still poor Poon and Fan, 2004] . Early diagnosis and treatment of HCC remain challenging due to lack of highly specific and sensitive markers. The currently used serological tumor marker for HCC, α-fetoprotein (AFP), lacks specificity and sensitivity [Johnson, 2001] .
Liver-Intestine cadherin (LI-cadherin), or CDH17 (cadherin-17) is a member of non-classical cadherin family [Jung et al., 2004] and located on chromosome 8q21.1 [Dantzig et al., 1994] . Beside the cell adhesion function, CDH17 was initially identified as a proton-dependent peptide transporter-1 in human colon adenocarcinoma Caco-2 cells [Dantzig et al., 1994] . CDH17 is over-expressed in gastric metaplasia and gastric carcinoma 42 associated with lymph node metastasis [Grotzinger et al., 2001; Kaposi-Novak et al., 2006; Ko et al., 2004; Ko et al., 2005] , as well as in pancreatic carcinoma [Takamura et al., 2003] . Recently, our group has reported CDH17 is over-expressed in HCC and is associated with poor survival rate and a higher tumor recurrence [Wang et al., 2005; Wong et al., 2003 ]. In human, over-expression of CDH17 is frequently detected in ~80% HCC cases, but the corresponding regulatory mechanisms remain largely unclear. and BMP4 in gastric cancer cells [Barros et al., 2008] .
HNF1 is one of the key transcriptional factors that regulate serum α-fetoprotein levels in hepatocellular carcinoma [Nakabayashi et al., 2004] . It is predominantly expressed in liver and kidney, and binds to the promoters of a variety of genes that are expressed exclusively in the liver including fibrinogen-α and -β, albumin, α-1-antitrypsin, liver-type pyruvate kinase, transthyretin, aldolase B, and hepatitis B virus large surface protein [Courtois et al., 1987; Xu et al., 2001] . Over-expression of HNF1α was found in well-differentiated HCC than in the surrounding non-HCC tissues [Wang et al., 1998 ].
In this study, we aimed to dissect the regulation of CDH17 expression in HCC and in mouse live during development, and functionally characterized two transcription factors (HNF1α and CDX2) on CDH17 expression. The specific regulation of these transcriptional factors was confirmed by RNAi approach in the transfected HCC cells. 
MATERIALS AND METHODS

Plasmids, bacteria and reagents
The Dual-Luciferase® reporter assay system and the pGL3-Basic, pGL3-Control and pRL-TK reporter vectors were obtained from Promega (Madison, WI). E. coli DH5α competent cells were prepared by chemical method. Restriction endonucleases, T4 DNA ligase and T4 polynucleotide kinase were purchased from New England Biolabs (Ipswich, MA). Bradford reagent was purchased from Bio-Rad (Hercules, CA) and all other reagents were purchased from Sigma (St. Louis, MO).
Mouse liver and clinical HCC tissues
The use of animal in this study protocol was approved by the Using Live Animals for were extracted from BALB/c mouse livers at different stages: embryonic day 13.5 (E13.5), E16.5, new-borne (NB), postnatal (3 weeks), and adult (3 months).
Cloning of 5'-promoter region of the CDH17 gene
The promoter region of the human CDH17 gene (NM_004063.3) was predicted and analyzed using the NCBI Map Viewer (http://www.ncbi.nlm.nih.gov/mapview). The 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   6 promoter fragment starting at -909bp and ending at +55bp was amplified by PCR using specific forward primer 5'-TAGAGAGTGGGCTGGGCTC-3' and reverse primer 5'-TGGTCGAGACTCTTGCTACG-3' and Pfu Turbo high-fidelity DNA polymerase (Stratagene, La Jolla, CA). In brief, PCR was carried out at 94 °C for 5 min and then 30 cycles at 94 °C for 40 s, 60 °C for 1 min, and 72 °C for 3 min and a final extension step at 72 °C for 10 min in a final reaction volume of 25 µl. The genomic DNA of HCC cell line MHCC97L was used as template and the CDH17 gene promoter was cloned by directional restriction cloning method [Lee et al., 2009; Wong et al., 2003 ].
Constructs of CDH17 mutant promoters
Another four deletion constructs (-686/+55, -332/+55, -81/+55 and -40/+55) were generated by PCR cloning with the following forward primers (5'-GAAGCCTTGACTTGAGAAAT-3', 5'-TGATCAAGTCTCCTGTGCT-3', 5'-AGTGGCTCTCGAAGAGCAAT-3', and 5'-TTTGACTGAAGCTGAAGGG-3'), respectively. These five CDH17 promoter constructs were cloned to the pGL3-Basic vector by XhoI/KpnI restriction digestions. For site-directed mutagenesis, mutated promoter constructs were generated using the QuickChange mutagenesis kit (Stratagene). All deletion and point-mutation constructs were sequenced with an ABI 3700 Genetic Analyzer (Applied Biosystems Inc., Foster City, CA).
Cell Cultures and transfection
The human HCC cell lines MHCC97L and Hep3B and a normal immortalized human 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 for 48 h, the promoter activity of the CDH17 gene was assessed by measuring luciferase activity using the Dual-Luciferase® reporter assay (Promega). The intensity of chemiluminscence was measured in a luminometer (Thermo, Waltham, MA). All experiments were performed in duplicate and repeated at least three times with positive (pGL3-Control) and negative (pGL3-Basic) controls.
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Western blotting
Antibodies against CDX2 and β-actin were purchased from Millipore (Billerica, MA) and Tris-buffered saline containing 0.1% Tween 20 (TBST) and 5% non-fat milk at 4°C
overnight [Lee et al., 2006] . After washing three times with TBST, the membrane was incubated with the primary antibodies (1:500 in TBST containing 5% non-fat milk) at room temperature for 1 h. After washing with TBST, bound antibodies were detected by horseradish peroxidase (HRP)-conjugated secondary antibodies (1:20,000 dilution) and ECL reagent (Amersham Biosciences). The immunoreactive signals were developed on Kodak® Biomax™ MS film.
Quantitative PCR
Total RNA was isolated from cell cultures or frozen tissues using Trizol reagent (Invitrogen). Two micrograms of total RNA were used to synthesize first-strand cDNA using random hexamer primers and reverse transcriptase (Promega). A 5 µl aliquot of 1:10 diluted cDNA was mixed with 10 µl SYBR® GreenERTM qPCR superMix (Invitrogen) and 0.5 µM of the designated primers ( Table 1 ). The thermal cycling conditions were 50 °C for 2 minutes, 95 °C for 10 minutes, followed by 40 cycles at 95 °C for 15 seconds and 60 °C for 1 minute. All reactions were done at least twice and the products were analyzed using the ABI Prism 7700 detection system (Applied Biosystems Inc.). Ribosomal 18S
RNA was included in all reactions for internal house-keeping control and normalization. Nuclear protein extracts from MHCC97L and Hep3B cells were prepared as described previously , and the amount of protein extract was quantified using the The resultant supernatant was diluted 1:10 with a dilution buffer containing a protease inhibitor. Twenty microliter of the diluted supernatant was collected as input control before immunoprecipitation. After precleared with 75 µL of salmon sperm DNA/protein A agarose (50% slurry) for 1 hour at 4°C with agitation, the immune complexes were incubated at 4°C overnight with either 2 µg of primary antibodies or IgG control, and then recovered with 60 µl of salmon sperm DNA/protein A agarose 50% slurry at 4°C for 1 hour.
Electromobility shift assay (EMSA)
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Precipitates were washed once sequentially with washing solutions provided by the manufacturer (Millipore), and finally with two washes of TE buffer. Chromatin complexes 
HNF1α and CDX2 siRNA knockdown
Small interference RNA (siRNA) was used to knockdown the expression of HNF1α and CDX2 in HCC cells (MHCC97L and Hep3B). RNA oligonucleotides were designed according to the published sequences [Hinoi et al., 2005] . HCC cells were transfected with the designated siRNA duplex or scramble control using Lipofectamine™ 2000 (Invitrogen)
as described above. After 48-hour incubation, both mRNA and protein extracts were purified for qPCR and Western blot analyses, respectively.
Statistical analysis
All results are represented as mean ± S.D. Statistical comparisons were performed by One-way ANOVA or paired Student's t-test using the SPSS statistical software package version 13.0 for Window (SPSS Inc., Chicago, IL) and p<0.05 was considered to be statistically significant. To confirm the functional roles of these transcriptional factors (TF), point mutations were introduced at the TF core binding sites in the CDH17 promoter sequence. and CDX2 (-91/-89) binding sites reduced the CDH17 reporter activity to near basal level.
Binding of CDX2 and HNF1α to CDH17 promoter in vitro and in vivo
The binding of HNF1 and CDX2 to the CDH17 gene promoter in MHCC97L and Hep3B cells were studied by EMSA and ChIP assays. As shown in Fig. 3A , both the HNF1α and CDX2 wild-type (WT), but not the mutant probes were able to complexes with the HCC lysates. Further, addition of 10 and 50-fold excess of "cold" WT probes, but not the mutant probes, could displace or compete with the binding. Moreover, CDX2, HNF1α, but not HNF1β antibodies were able to retard the migration of the DNA-protein complex, suggesting the binding of the nuclear extract is specific. Meanwhile, the ChIP assay was performed to study TF-DNA interactions in vivo. After immunoprecipitation by designated antibodies, the recovered DNA was amplified by PCR using CDH17 promoter-specific primers spanning from -318 to -18 regions. Positive signals were detected by the HNF1α and CDX2, but not the HNF1β and isotype control (Fig. 3B ).
Differential expression of CDH17, HNF1 and CDX in HCC and fetal mouse liver
Luciferase reporter assays revealed differential promoter activities in Hep3B and MHCC97L cell lines (Fig. 1B and Fig. 2 ). To study if the endogenous CDH17 transcript level correlates with the HNF1α and CDX2 expression levels, we determined the (Fig. 4A ).
Since CDH17 plays important roles during embryonic liver development, the expression of CDH17 and TFs levels in mouse liver at different development stages (E13.5, E16.5, newborn, 3 weeks and adult) were measured. Bioinformatics analysis of these transcriptional factor binding sites on CDH17 promoter between mouse, rat and human are highly conserved using ClustalW2 program (http://www.ebi.ac.uk/ Tools/clustalw2/index.html), suggesting a conserved regulatory mechanism of CDH17 expression among different animal species (data not shown). It was found that CDH17 expressed abundantly in the early embryonic liver, but the expression of the gene becomes undetectable in late fetal stages and adult livers (Fig. 4A) . Similar to the human HCC findings, the differential expression of CDH17 transcript in mouse liver largely correlated with the patterns of HNF1α and CDX2 levels. The result was supported by Western blot analysis of the CDH17, HNF1α and CDX2 protein levels (Fig. 4B) . Interestingly, the decreases of CDH17 and HNF1a were more drastic in both human HCC cells and mouse livers, than the CDX2.
Knockdown of HNF1α and CDX2 suppress CDH17 expression
To demonstrate HNF1α and CDX2 regulate CDH17 expression, we used siRNA approach [Angres et al., 2001] , as well as in the embryonic mouse liver [Takamura et al., 2004] , but no CDH17 expression was detected in normal liver tissue of mature humans and mice [Takamura et al., 2003] . CDH17 is involved in the maintenance of tissue integrity, tissue growth and differentiation [Berndorff et al., 1994] . Aberrant expression of CDH17 mRNA and protein was found in upper gastrointestinal malignancies including liver cancer [Wang et al., 2006; Wang et al., 2005; Wong et al., 2003] . In this study, we demonstrated that the expression of CDH17 is regulated by HNF1α and CDX2 transcriptional factors in HCC and mouse liver.
The human CDH17 gene promoter has a conserved CAAT box at the -65/-62 position, but lacks the TATA box, an initiator element in the predominant control region of typical eukaryotic genes [Suzuki et al., 2001] . In both primary and metastatic human HCC cell lines, the minimal CDH17 promoter (-81/-40) region contains one CDX2 and two HNF1 sites that mediated strong promoter activity in vitro. Further deletion of this minimal promoter region diminished the reporter activity to near basal levels. We also found that the transactivation activitiy of the pGL3-81/+55Luc construct was similar to longer constructs (up to -909 position). Although the deletion construct pGL3-332/+55Luc shown a decrease in promoter activity, the reason behind is still unknown. It is possible that an enhancer sequence is located at -686 and -332 region, and a repressor sequence is located at -32 to -81 region, thereby modulate the changes in promoter activity. As a result, the deletion construct pGL3-81/+55Luc shown a full-promoter activity. Yet, further HNF1 and CDX2 are homeodomain transcription factors that regulate a number of intestine-specific genes including Lewis type 1 antigen synthase (β3Gal-T5) and UDP-glucuronosyltransferases (UGT) [Gregory et al., 2004; Isshiki et al., 2003] . CDX2
regulates CDH17 expression in colorectal cancer cell lines and gastric adenocarcinoma [Barros et al., 2008; Hinoi et al., 2002; Ko et al., 2005] . In this study, 3 putative CDX2-binding sites were found in the 1-kb CDH17 promoter region (Fig. 1A) and it is the -91/-89 site that contributed to CDH17 promoter activity and binding in HCC. In addition, we identified HNF1 homeobox A (HNF1α) that may play an important role in regulating 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Fig. 1B and Fig. 2 ).
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HNF1α and HNF1β are two related transcriptional factors that bind to DNA as homo-or heterodimers. They were identified initially as liver-enriched transcription factors that were involved in the expression of several plasma proteins including α1-antitrypsin [Mendel and Crabtree, 1991] . However, no detectable HNF1β transcript and protein was found in the two HCC cell lines studied (data not shown), and HNF1β failed to bind to CDH17 promoter DNA sequence in EMSA or ChIP assays. These findings suggest that
HNF1α, but not HNF1β is associated with the regulation of the CDH17 gene in HCC.
Interestingly, HNF1β has recently been demonstrated to direct the expression of kidney-specific cadherin (cadherin-16) [Bai et al., 2002] .
In conclusion, the present study provides the first evidence that HNF1α plays a critical role, together with CDX2, on the regulation of CDH17 gene expression in HCC as well as in early stages of fetal liver development in mice. Clinically, over-expression of CDH17 in HCC is associated with poor clinical outcomes; HNF1α and CDX2 in accompany with CDH17 may be potential therapeutic targets for disease diagnosis and treatment.
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